CALCA and Hepatitis: In this study, we investigated the effect of evogliptin on the release and expression of inflammatory and fibrotic mediators from primary KC, primary hepatocytes, and primary HSC, to determine if evogliptin might directly protect against liver inflammation and fibrosis.